GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.00
Bid: 14.50
Ask: 15.50
Change: 0.00 (0.00%)
Spread: 1.00 (6.897%)
Open: 15.25
High: 15.25
Low: 14.75
Prev. Close: 15.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Australia shares ease for 4th day as financials drag; NZ higher

Wed, 04th Apr 2018 04:10

* ANZ falls for the eighth straight day

* Fonterra slightly lower after NZ milk production falls inFeb

By Susan Mathew

April 4 (Reuters) - Australian shares eased for a fourthconsecutive day on Wednesday, dampened by weakness in financialstocks, although gains in the defensive healthcare sector cappedoverall losses.

The S&P/ASX 200 index fell 5.7 points to 5,747.2 by0225 GMT. The benchmark closed 0.1 percent lower on Tuesday.

Financials are under pressure as they are a currency proxy,said Mathan Somasundaram, market portfolio strategist, BlueOcean Equities.

"The market is beginning to see a bounce in the U.S. dollarand the Aussie dollar is falling, which means you'll seeexposure reduction by global investors in Australia, and thathits the big banks."

The Aussie is hovering near four-month lows, hurtby the outlook for global growth amid escalating U.S.-Chinatrade tensions.

Australia and New Zealand Banking Group posted itseighth straight losing session, down 1 percent, while otherlenders among the 'Big Four' fell between 0.4 percent and 0.7percent.

Mining giant BHP was marginally higher after havingfallen as much as 0.4 percent. Iron ore on the Daliancommodities exchange snapped a five-day gaining streak onTuesday, and was 1.3 percent lower at 0225 GMT.

Weaker bullion hit gold stocks with Newcrest Miningdropping 1.3 percent.

Rio Tinto and Fortescue Metals, however,edged higher. Fortescue saw a rating upgrade to 'buy' fromDeutsche Bank.

CSL Ltd led gains among healthcare stocks, risingas much as 2 percent, its best one-day gain in more than threeweeks.

"I think that (healthcare) is pretty much a safety play atthis point, as most of the stocks in the healthcare sector likeCSL, Cochlear are way overvalued, if you look at it onhistorical terms," Somasundaram added.

Cochlear, however, was slightly lower for the day.

The biggest power producer in Australia, AGL Energy, rose as much as 0.3 percent, before trading flat afterAlinta Energy, owned by Hong Kong's Chow Tai Fook Enterprises,expressed an interest in acquiring its coal-fired Liddell PowerStation in New South Wales state.

New Zealand's benchmark S&P/NZX 50 index rose 0.2percent, or 16.27 points, to 8,346.2.

Dairy company a2 Milk and Auckland InternationalAirport pushed up the index the most. A2 was up 3percent, while Auckland edged 0.8 percent higher.

The world's biggest dairy exporter Fonterrawas marginally lower after it said its New Zealand milkoutput in February fell 2 percent.

For more individual stocks activity click on(Reporting by Susan Mathew in Bengaluru; Additional reportingby Ambar Warrick;Editing by Jacqueline Wong)

More News
20 Oct 2020 14:18

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

Read more
20 Oct 2020 08:58

FDA accepts Angle's review submission for Parsortix PC1

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

Read more
28 Sep 2020 19:33

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

Read more
20 Aug 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.